Starpharma partners with Gowan on Priostar agrochemical

Starpharma Holdings and Gowan Company recently announced a new partnership using Starpharma’s Priostar® dendrimer technology in crop protection formulations.

Under the agreement, Starpharma’s Priostar® dendrimers will be evaluated as potential enhancements for certain Gowan products intended for high value markets.

The partnership with Gowan, a US-based company with global agrochemical sales of more than US$300 million, aims to broaden crop protection offerings and open new markets through the use of Starpharma’s Priostar® dendrimer technology. 

“We are excited at the prospect of working with Gowan to develop new formulation options using our Priostar® dendrimers for high value markets,” said Starpharma Chief Executive Officer Dr. Jackie Fairley. “Gowan’s focus on providing tailored solutions to farmers’ problems fits well with our technology’s capabilities.”

“At Gowan we are proud of our history of providing a complete offering to farmers and we are very pleased to be able to include Starpharma’s innovative technology for potential improvements to our crop protection formulations,” said Sandra Alcaraz, Disruptive Technologies Manager.

“With a strong product portfolio and international distribution network, we are able to effectively apply innovative technologies in crop protection products for our key markets.”

The benefits of Starpharma’s Priostar® dendrimers to agrochemical companies and end-user growers can include:
• Improved product efficacy;
• More concentrated formulations to reduce supply chain costs and for greater ease of handling;
• Reduction in solvent loading; and
• Improved bioavailability through increased adhesion, to reduce losses due to rain run-off, and the need for multiple applications.

Starpharma continues to advance the commercialisation of Priostar® for crop protection applications via both an internal research program and through valued partnerships with other crop protection companies.